Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Subscribe To Our Newsletter & Stay Updated